Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

156
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
156
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

103
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
103
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

5.5K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Delivery Strategies for Colchicine as a Critical Dose Drug: Reducing Toxicity and Enhancing Efficacy.

Pharmaceutics·2024
Same author

Occult urothelial carcinoma with mediastinal metastasis: A case report.

Oncology letters·2024
Same author

Phase Identification and Discovery of an Elusive Polymorph of Drug-Polymer Inclusion Complex Using Automated 3D Electron Diffraction.

Angewandte Chemie (International ed. in English)·2024
Same author

Mediating and moderating effects of authoritative parenting styles on adolescent behavioral problems.

Frontiers in psychology·2024
Same author

A transformer-based diffusion probabilistic model for heart rate and blood pressure forecasting in Intensive Care Unit.

Computer methods and programs in biomedicine·2024
Same author

Scalable production of recombinant three-finger proteins: from inclusion bodies to high quality molecular probes.

Microbial cell factories·2024

Related Experiment Video

Updated: Jun 10, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

223

Agnostic-Specific Modality Learning for Cancer Survival Prediction From Multiple Data.

Honglei Liu, Yi Shi, Ying Xu

    IEEE Journal of Biomedical and Health Informatics
    |October 15, 2024
    PubMed
    Summary

    This study introduces a new framework for cancer survival prediction by integrating diverse data types like images and genomics. The method effectively bridges data gaps and reduces redundancy for improved accuracy.

    More Related Videos

    Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
    04:09

    Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

    Published on: October 10, 2018

    8.2K
    Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
    07:15

    Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

    Published on: August 16, 2020

    6.7K

    Related Experiment Videos

    Last Updated: Jun 10, 2025

    Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
    06:46

    Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

    Published on: September 27, 2024

    223
    Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
    04:09

    Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

    Published on: October 10, 2018

    8.2K
    Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
    07:15

    Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

    Published on: August 16, 2020

    6.7K

    Area of Science:

    • Oncology
    • Computational Biology
    • Bioinformatics

    Background:

    • Cancer is a leading global cause of mortality, necessitating improved survival prediction.
    • Accurate prediction aids clinicians in developing effective treatment strategies and enhancing patient quality of life.
    • Integrating diverse data, including pathological images and genomics, is key to advancing cancer survival prediction.

    Purpose of the Study:

    • To propose a novel agnostic-specific modality learning (ASML) framework for accurate cancer survival prediction.
    • To address challenges of modality gap and semantic redundancy in multimodal cancer data.
    • To enhance the comprehensive integration of diverse cancer-related data for improved predictive performance.

    Main Methods:

    • Developed an agnostic-specific learning strategy to identify commonalities and unique features across different data modalities.
    • Employed a cross-modal fusion network to integrate multimodal information by modeling correlations.
    • Utilized a divide-and-conquer approach to diminish semantic redundancy within integrated data.

    Main Results:

    • The ASML framework demonstrated superior performance compared to existing methods in cancer survival prediction.
    • Experiments were conducted on three The Cancer Genome Atlas (TCGA) datasets, validating the framework's effectiveness.
    • The proposed method successfully bridged the modality gap and reduced semantic redundancy in multimodal cancer data.

    Conclusions:

    • The ASML framework offers a significant advancement in multimodal cancer survival prediction.
    • This approach effectively integrates diverse data sources, overcoming key challenges in the field.
    • ASML provides a promising computational tool for improving cancer patient outcomes and treatment planning.